Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Hydroxychloroquine by PureIMS for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Hydroxychloroquine is under clinical development by PureIMS and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
Data Insights
Amikacin by PureIMS for Tuberculosis: Likelihood of Approval
Amikacin is under clinical development by PureIMS and currently in Phase I for Tuberculosis. According to GlobalData, Phase I drugs...